$NRX gains traction in Europe with Orphan drug designation NurExone gains traction in Europe with Orphan drug designation awarded by regulator (TSXV: NRX) (FSE: J90) (NRX.V)
https://10xalerts.com/nurexone-gains-traction-in-europe-with-orphan-drug-designation-awarded-by-regulator-tsxv-nrx-fse-j90-nrx-v/